We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Computerized Screening, Brief Intervention, and Referral to Treatment in Primary Care (SBIRT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01003834
First Posted: October 29, 2009
Last Update Posted: December 8, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Virginia Commonwealth University
  Purpose

This is a randomized, controlled clinical trial to evaluate the effect of a computerized screening, assessment, and brief intervention on substance use in patients recruited from a primary care clinic. Study participants will be assigned to one of the following 4 study groups: computerized health screening alone (standard care) (SC); computerized assessment-only intervention (CA); computerized assessment followed by a computer-directed motivational intervention (CACI); or computerized assessment followed by a therapist-delivered motivational intervention (CATI). Data regarding substance use, medical and psychosocial functioning, and economic outcomes will be collected.

The investigators hypothesize that patients randomized to CACI and CATI will be more likely to report drug abstinence at the 3-month follow-up visit and will show greater reductions in drug use at 1, 3 and 6 months follow-up than patients assigned to CA or SC. Similarly, patients in the CACI and CATI groups will report greater reductions in HIV risk behaviors, lower rates of medical and psychosocial problems, and increased economic gains at the 6-month follow-up. In addition, patients in the assessment only intervention (CA) will have outcomes superior to those found for SC patients. A cost-effectiveness analysis will also be done comparing economic costs associated with CA, CACI and CATI and their relationship to substance use reductions and related improvements in medical and psychosocial outcomes at the 6 month follow-up.


Condition Intervention
Substance Use Disorder Behavioral: Computerized brief intervention Behavioral: Computerized health screening Behavioral: Computerized assessment Behavioral: Therapist-delivered motivational intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Computer vs Therapist-Delivered Brief Interventions for Substance Use in Primary Care

Further study details as provided by Virginia Commonwealth University:

Primary Outcome Measures:
  • Substance use [ Time Frame: 3 months ]

Enrollment: 713
Study Start Date: November 2011
Study Completion Date: July 2014
Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Control
Screening only
Behavioral: Computerized health screening
Behavioral intervention
Active Comparator: Assessment
Screening plus assessment
Behavioral: Computerized health screening
Behavioral intervention
Behavioral: Computerized assessment
Behavioral intervention
Experimental: Computer Intervention
Screening, assessment, and computer-delivered intervention
Behavioral: Computerized brief intervention
Intervention based on Motivational Interviewing technique
Behavioral: Computerized health screening
Behavioral intervention
Behavioral: Computerized assessment
Behavioral intervention
Active Comparator: Therapist Intervention
Screening, Assessment, and therapist-delivered intervention
Behavioral: Computerized health screening
Behavioral intervention
Behavioral: Computerized assessment
Behavioral intervention
Behavioral: Therapist-delivered motivational intervention
Behavioral intervention

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18 - 65 years
  • Primary care clinic patient

Exclusion Criteria:

  • Pregnant
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01003834


Locations
United States, Virginia
Virginia Commonwealth University
Richmond, Virginia, United States, 23298
Sponsors and Collaborators
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Dace Svikis, PhD Virginia Commonwealth University
  More Information

Responsible Party: Virginia Commonwealth University
ClinicalTrials.gov Identifier: NCT01003834     History of Changes
Other Study ID Numbers: SBIRTVCU
R01DA026091 ( U.S. NIH Grant/Contract )
First Submitted: October 27, 2009
First Posted: October 29, 2009
Last Update Posted: December 8, 2015
Last Verified: December 2015

Keywords provided by Virginia Commonwealth University:
substance use
drug use
drug abuse

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders